These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 38772208

  • 1. Analysis of potential microRNA biomarkers for multiple sclerosis.
    Al-Temaimi R, Alshammari N, Alroughani R.
    Exp Mol Pathol; 2024 Jun; 137():104903. PubMed ID: 38772208
    [Abstract] [Full Text] [Related]

  • 2. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
    Sağır F, Ersoy Tunalı N, Tombul T, Koral G, Çırak S, Yılmaz V, Türkoğlu R, Tüzün E.
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
    [Abstract] [Full Text] [Related]

  • 3. Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis.
    Agostini S, Mancuso R, Citterio LA, Caputo D, Oreni L, Nuzzi R, Pasanisi MB, Rovaris M, Clerici M.
    Neurobiol Dis; 2024 Oct 01; 200():106648. PubMed ID: 39181188
    [Abstract] [Full Text] [Related]

  • 4. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
    Ebrahimkhani S, Vafaee F, Young PE, Hur SSJ, Hawke S, Devenney E, Beadnall H, Barnett MH, Suter CM, Buckland ME.
    Sci Rep; 2017 Oct 30; 7(1):14293. PubMed ID: 29084979
    [Abstract] [Full Text] [Related]

  • 5. miR-24-3p and miR-484 are potential biomarkers for neurodegeneration in multiple sclerosis.
    Al-Temaimi R, Alroughani R.
    Heliyon; 2024 Jun 30; 10(12):e32685. PubMed ID: 38975190
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
    Mosarrezaii Aghdam A, Rezaei S, Zarza Nalivan F, Babaie F, Amiri Nikpour MR, Torkamandi S.
    Immunol Invest; 2022 Jul 30; 51(5):1149-1161. PubMed ID: 33866949
    [Abstract] [Full Text] [Related]

  • 8. Serum ROCK2, miR-300 and miR-450b-5p levels in two different clinical phenotypes of multiple sclerosis: Relation to patient disability and disease progression.
    Ibrahim SH, El-Mehdawy KM, Seleem M, El-Sawalhi MM, Shaheen AA.
    J Neuroimmunol; 2020 Oct 15; 347():577356. PubMed ID: 32781341
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
    Vistbakka J, Elovaara I, Lehtimäki T, Hagman S.
    Mult Scler; 2017 Mar 15; 23(3):403-412. PubMed ID: 27246141
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNAs Correlate with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in a Chinese Population.
    Chen J, Zhu J, Wang Z, Yao X, Wu X, Liu F, Zheng W, Li Z, Lin A.
    Med Sci Monit; 2017 May 27; 23():2565-2583. PubMed ID: 28550707
    [Abstract] [Full Text] [Related]

  • 16. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases.
    Sharaf-Eldin WE, Kishk NA, Gad YZ, Hassan H, Ali MAM, Zaki MS, Mohamed MR, Essawi ML.
    J Neurol Sci; 2017 Dec 15; 383():188-198. PubMed ID: 29246612
    [Abstract] [Full Text] [Related]

  • 17. Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study.
    Gonzalez-Martinez A, Bose G, Lokhande H, Saxena S, Healy BC, Polgar-Turcsanyi M, Weiner HL, Chitnis T.
    J Neuroinflammation; 2023 Jun 01; 20(1):136. PubMed ID: 37264432
    [Abstract] [Full Text] [Related]

  • 18. MiRNA 106a-5p in cerebrospinal fluid as signature of early relapsing remitting multiple sclerosis: a cross sectional study.
    Zanghì A, Manuti V, Serviddio G, D'Amico E, Avolio C.
    Front Immunol; 2023 Jun 01; 14():1226130. PubMed ID: 37711630
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients.
    Zanoni M, Orlandi E, Rossetti G, Turatti M, Calabrese M, Gomez Lira M, Gajofatto A.
    Acta Neurol Scand; 2020 Nov 01; 142(5):511-516. PubMed ID: 32432792
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.